Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Childhood leukemia linked to lack of childhood infections

Childhood leukemia linked to lack of childhood infections

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

New treatment regimen boosts survival for young adults and children with T-cell malignancies

New treatment regimen boosts survival for young adults and children with T-cell malignancies

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

New case study shows CAR T therapy as viable option for AML patients

New case study shows CAR T therapy as viable option for AML patients

Targeted 'click-to-release' chemotherapy leads to potent antitumor activity in mice

Targeted 'click-to-release' chemotherapy leads to potent antitumor activity in mice

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

Researchers discover new information related to rare form of leukemia

Researchers discover new information related to rare form of leukemia

Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens

Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New insights into breast implant-associated anaplastic large-cell lymphoma

New insights into breast implant-associated anaplastic large-cell lymphoma

Without context or cushion, Do online medical results make sense?

Without context or cushion, Do online medical results make sense?

MSU scientists test promising drug to prevent cancer in high-risk patients

MSU scientists test promising drug to prevent cancer in high-risk patients

Researchers propose alternative treatment to target lymphoma signaling at its root

Researchers propose alternative treatment to target lymphoma signaling at its root

Discovery of genes could lead to development of novel therapies for EBV-related cancers

Discovery of genes could lead to development of novel therapies for EBV-related cancers

Adolescent, young adult cancer survivors have stronger social networks than non-cancer peers

Adolescent, young adult cancer survivors have stronger social networks than non-cancer peers